{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:57:23Z","timestamp":1778126243977,"version":"3.51.4"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>OBJECTIVES. The purpose of this work was to determine whether visual impairment caused by toxoplasmic chorioretinitis is associated with impaired performance of specific tasks on standardized tests of cognitive function. If so, then we worked to determine whether there are patterns in these difficulties that provide a logical basis for development of measures of cognitive function independent of visual impairment and compensatory intervention strategies to facilitate learning for such children.<\/jats:p><jats:p>METHODS. Sixty-four children with congenital toxoplasmosis with intelligence quotient scores \u226550 and visual acuity sufficient to cooperate with all of the intelligence quotient subscales had assessments of their vision, appearance of their retinas, and cognitive testing performed between 3.5 and 5 years of age. These evaluations took place between 1981 and 1998 as part of a longitudinal study to determine outcome of congenital toxoplasmosis. Children were evaluated at 3.5 or 5 (37 children) or both 3.5 and 5 (27 children) years of age. Cognitive function was measured using the Wechsler Preschool and Primary Scale of Intelligence-Revised. Wechsler Preschool and Primary Scale of Intelligence-Revised scale scores were compared for children grouped as those children who had normal visual acuity in their best eye (group 1), and those who had impaired vision in their best eye (acuity &amp;lt;20\/40) because of macular disease (group 2). Demographic characteristics were compared for children in the 2 groups. Test scores were compared between groups using all of the 3.5-year-old visits, all of the 5-year-old visits, and using each child's \u201clast\u201d visit (ie, using the 5-year-old test results when a child was tested at both 3.5 and 5 years of age or only at 5 years, otherwise using the 3.5-year-old test results). The results were similar and, therefore, only the results from the last analysis are reported here.<\/jats:p><jats:p>RESULTS. There were 48 children with normal visual acuity in their best eye (group 1) and 16 children with impaired vision because of macular involvement in their best eye (group 2). Ethnicity and socioeconomic scores were similar. There was a significantly greater proportion of males in group 2 compared with group 1 (81% vs 46%). There was no significant diminution in Wechsler Preschool and Primary Scale of Intelligence-Revised test scores between 3.5 and 5 years of age for the 27 children tested at both of these ages. Verbal intelligence quotient, performance intelligence quotient, full-scale intelligence quotient scores, and all of the scaled scores except arithmetic and block design were significantly lower for children in group 2 compared with group 1. The majority of the differences remained statistically significant or borderline significant after adjusting for gender. However, the difference in overall verbal scores does not remain statistically significant. Mean \u00b1 SD verbal (98 \u00b1 20) and performance (95 \u00b1 17) intelligence quotients were not significantly different for children in group 1. However, verbal (88 \u00b1 13) and performance intelligence quotients (78 \u00b1 17) were significantly different for children in group 2. For children in group 2, their lowest scale scores were in object assembly, geometric design, mazes, and picture completion, all timed tests that involved visual discrimination of linear forms with small intersecting lines. In the 2 scales scored that did not differ between groups 1 and 2, arithmetic and block design, timing and vision but not linear forms were components of the tasks. Children with monocular and binocular normal visual acuity did not differ in verbal, performance, or full-scale intelligence quotients or any of the subscale tests. Difficulty with sight or concomitant neurologic involvement also seemed to impact the ability to acquire information, comprehension skills, and vocabulary and performance in similarities testing. After controlling for gender, however, these differences were diminished, and there were no longer differences in overall verbal scores. As noted above, results were generally similar when all of the tests for 3.5-year-olds or 5-year-olds were analyzed separately. At the 3.5-year visit there were fewer significant differences between the 2 groups for the verbal components than at the 5-year visit.<\/jats:p><jats:p>CONCLUSIONS. In children with congenital toxoplasmosis and bilateral macular disease (group 2) because of toxoplasmic chorioretinitis, scaled scores were lowest on timed tests that require discrimination of fine intersecting lines. Although the severity of ocular and neurologic involvement is often congruent in children with congenital toxoplasmosis, ophthalmologic involvement seems to account for certain specific limitations on tests of cognitive function. Children with such visual impairment compensate with higher verbal skills, but their verbal scores are still less than those of children with normal vision, and in some cases significantly so, indicating that vision impairment might affect other aspects of cognitive testing. Patterns of difficulties noted in the subscales indicate that certain compensatory intervention strategies to facilitate learning and performance may be particularly helpful for children with these impairments. These patterns also provide a basis for the development of measures of cognitive function independent of visual impairment.<\/jats:p>","DOI":"10.1542\/peds.2005-1530","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T00:24:51Z","timestamp":1153787091000},"page":"e379-e390","source":"Crossref","is-referenced-by-count":47,"title":["Impact of Visual Impairment on Measures of Cognitive Function for Children With Congenital Toxoplasmosis: Implications for Compensatory Intervention Strategies"],"prefix":"10.1542","volume":"118","author":[{"given":"Nancy","family":"Roizen","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Psychiatry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Kasza","sequence":"additional","affiliation":[{"name":"Health Studies"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Karrison","sequence":"additional","affiliation":[{"name":"Health Studies"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Mets","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Northwestern University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Gwendolyn","family":"Noble","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Northwestern University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Boyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Infectious Diseases, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Swisher","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children's Memorial Hospital, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, Columbia University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Remington","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Stanford University and Palo Alto Medical Research Foundation, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Jalbrzikowski","sequence":"additional","affiliation":[{"name":"Ophthalmology and Visual Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"McLeod","sequence":"additional","affiliation":[{"name":"Ophthalmology, Medicine, Pediatrics, Infectious Disease, and Pathology, Committees on Immunology, Molecular Medicine, and Genetics, University of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"other members of the Toxoplasmosis Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"2021120822410382800_R1","unstructured":"Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn. 4th ed. Philadelphia, PA: WB Saunders; 2000:140\u2013267"},{"key":"2021120822410382800_R2","doi-asserted-by":"crossref","unstructured":"Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc.\u20081990;2:249\u2013256","DOI":"10.2460\/javma.1990.196.02.249"},{"key":"2021120822410382800_R3","doi-asserted-by":"crossref","unstructured":"Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthal.\u20081996;122:309\u2013324","DOI":"10.1016\/S0002-9394(14)72057-4"},{"key":"2021120822410382800_R4","unstructured":"Eichenwald HG. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae, and therapy. In: Siim JC, ed. Human Toxoplasmosis. Copenhagen, Denmark: Munksgaard; 1960;41\u201349"},{"key":"2021120822410382800_R5","doi-asserted-by":"crossref","unstructured":"Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics.\u20081980;66:767\u2013774","DOI":"10.1542\/peds.66.5.767"},{"key":"2021120822410382800_R6","doi-asserted-by":"crossref","unstructured":"Koppe JG, Kloosterman GJ, de Roever-Bonnet H, EckertStoink JA, Loewer-Sieger DH, de Braijue JL. Toxoplasmosis and pregnancy, with a long-term follow-up of the children. Eur J Obstet Gynecol Reprod Biol.\u20081974;413:101\u2013110","DOI":"10.1016\/0028-2243(74)90029-X"},{"key":"2021120822410382800_R7","doi-asserted-by":"crossref","unstructured":"Koppe JG, Loewer-Seiger DH, DeRoever-Bonnet H. Results of 20 year follow-up of congenital toxoplasmosis. Lancet.\u20081986;1:254\u2013256","DOI":"10.1016\/S0140-6736(86)90785-3"},{"key":"2021120822410382800_R8","unstructured":"Couvreur J, Desmonts G, Tournier G, Szusterkac M. Study of a homogenous series of 210 cases of congenital toxoplasmosis in infants aged 0 to 11 months detected prospectively. Ann Pediatr.\u20081984;1:815\u2013819"},{"key":"2021120822410382800_R9","unstructured":"Couvreur J, Desmonts G, Aron-Rosa D. Le prognostic oculaire de la toxoplasmose congenitale: role du traitement. Ann Pediatr.\u20081984;31:855\u2013858"},{"key":"2021120822410382800_R10","doi-asserted-by":"crossref","unstructured":"McAuley JB, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis.\u20081994;18:38\u201372","DOI":"10.1097\/00006454-199409000-00033"},{"key":"2021120822410382800_R11","doi-asserted-by":"crossref","unstructured":"McLeod R, Mack D, Foss R, et al. Levels of pyrimethamine in sera and cerebrospinal fluid and ventricular fluids from infants treated for congenital toxoplasmosis. Antimicrob Agents Chemother.\u20081992;36:1040\u20131048","DOI":"10.1128\/AAC.36.5.1040"},{"key":"2021120822410382800_R12","doi-asserted-by":"crossref","unstructured":"McGee T, Wolters C, Stein L, et al. Absence of sensorineural hearing abnormalities in treated infants with congenital toxoplasmosis. Otolaryngol Head Neck Surg.\u20081992;106:75\u201380","DOI":"10.1177\/019459989210600131"},{"key":"2021120822410382800_R13","unstructured":"Roizen N, Swisher C, Stein M, et al. Neurologic and development outcome in treated congenital toxoplasmosis. Pediatrics.\u20081995;95:11\u201320"},{"key":"2021120822410382800_R14","unstructured":"Swisher CN, Boyer K, McLeod R. Congenital toxoplasmosis. Bodensteiner JB, ed. Semin Pediatr Neurol.\u20081994;1:4\u201325"},{"key":"2021120822410382800_R15","doi-asserted-by":"crossref","unstructured":"Patel DV, Holfels EM, Vogel NP, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology.\u20081996;199:433\u2013440","DOI":"10.1148\/radiology.199.2.8668790"},{"key":"2021120822410382800_R16","unstructured":"Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: Department of Sociology, Yale University; 1975"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e379\/1074260\/zpe0080600e379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e379\/1074260\/zpe0080600e379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T14:33:30Z","timestamp":1707143610000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/2\/e379\/69011\/Impact-of-Visual-Impairment-on-Measures-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,8,1]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1530","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}